Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-04

FDA Approved: PIMECROLIMUS — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Pimecrolimus from Oceanside Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

SUPPL AP for PIMECROLIMUS (PIMECROLIMUS)